DMC Biotechnologies
U.S.-based ingredient company that develops high‑purity bioactive ingredients using precision fermentation. The company applies a standardized two‑stage fermentation platform and dynamic metabolic control methods to improve predictability and accelerate scale‑up for nutraceutical, food, and personal care ingredient production. Initial commercial portfolio includes fermentation‑produced myo‑inositol and D‑chiro‑inositol and the company publishes tools and partners with external manufacturers and commercial distributors.
Industries
Nr. of Employees
medium (51-250)
DMC Biotechnologies
Products
Fermentation‑produced myo‑inositol ingredient
High‑purity myo‑inositol manufactured by precision fermentation from purified, food‑grade dextrose, supplied with defined specifications and traceability for nutrition and personal care applications.
Fermentation‑produced D‑chiro‑inositol ingredient
High‑purity D‑chiro‑inositol manufactured by the same controlled fermentation platform as myo‑inositol, offered as a matched ingredient pair for specific formulation ratios used in metabolic and reproductive health applications.
Fermentation‑produced myo‑inositol ingredient
High‑purity myo‑inositol manufactured by precision fermentation from purified, food‑grade dextrose, supplied with defined specifications and traceability for nutrition and personal care applications.
Fermentation‑produced D‑chiro‑inositol ingredient
High‑purity D‑chiro‑inositol manufactured by the same controlled fermentation platform as myo‑inositol, offered as a matched ingredient pair for specific formulation ratios used in metabolic and reproductive health applications.
Services
Provision of product specifications and samples to support formulation and qualification.
Technical guidance for applying fermentation‑produced ingredients in dietary supplements, functional foods/beverages and personal care products.
Management of technology transfer and coordination with contract manufacturers and external sites for fermentation and downstream processing.
Provision of product specifications and samples to support formulation and qualification.
Technical guidance for applying fermentation‑produced ingredients in dietary supplements, functional foods/beverages and personal care products.
Management of technology transfer and coordination with contract manufacturers and external sites for fermentation and downstream processing.
Expertise Areas
- Precision fermentation for bioactive ingredients
- Dynamic metabolic control and strain engineering
- Bioprocess scale‑up and technology transfer
- Downstream purification and product release testing
Key Technologies
- Precision fermentation
- Dynamic metabolic control / two‑stage fermentation
- Synthetic metabolic valves (production‑stage switching)
- Strain engineering and inducible degradation
News & Updates
Completed first close of Series B fundraising with multiple investors to accelerate commercialization.
Commercial launch of a fermentation‑produced D‑chiro‑inositol ingredient for nutraceutical applications.
Collaboration to develop a sustainable, fermentation‑produced high‑volume chemical intermediate.
Agreement to bring L‑alanine and branched‑chain amino acids into ASEAN markets via SCG.
Successful demonstration of fermentation scale‑up with performance matching bench and pilot results, validating platform predictability.
Completed downstream purification for L‑alanine at industrial partner site with product meeting customer specifications; >6,000 kg processed.
Completed first close of Series B fundraising with multiple investors to accelerate commercialization.
Commercial launch of a fermentation‑produced D‑chiro‑inositol ingredient for nutraceutical applications.
Collaboration to develop a sustainable, fermentation‑produced high‑volume chemical intermediate.
Agreement to bring L‑alanine and branched‑chain amino acids into ASEAN markets via SCG.
Successful demonstration of fermentation scale‑up with performance matching bench and pilot results, validating platform predictability.
Completed downstream purification for L‑alanine at industrial partner site with product meeting customer specifications; >6,000 kg processed.